Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System
Clinical trial NCT03614910 · COMPLETED
Trial details
- NCT number
- NCT03614910
- Sponsor
- Holy Name Medical Center, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-15
- Primary completion
- 2021-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.